-
Mashup Score: 5
DREAMM-8 phase III trial showed statistically significant and clinically meaningful improvement.
Source: us.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 3A strategic solution to preventing the harm associated with ambulance handover delays. | PSNet - 15 hour(s) ago
Delayed handovers from emergency medical services (EMS) to the emergency department (ED) can significantly increase the risk of medical complications. This article describes a two-phase quality improvement project to decrease overall handover times as well the percentage of handovers occurring more than 60 minutes after arrival. Strategies included creation of a designated area for patients awaiting hospital admission, detailed written policies, and regular meetings between ED staff and ambulance services to improve working relationships and communication. This resulted in a decrease in the percentage of handovers more than 60 minutes after arrival from 9% to 0.2%, and an increase from 52% to 69% of handovers completed in 15 minutes or less.
Source: psnet.ahrq.govCategories: General Medicine News, PayerTweet
-
Mashup Score: 13Measuring Primary Healthcare Spending - 15 hour(s) ago
The purpose of this Technical Brief is to build on these prior efforts and expand the included information, particularly as the number of State Governments producing estimates of primary care spending has grown. The focus of this brief is on comparing and contrasting the definitions, data sources, and methods used across estimates of primary care spending.
Source: effectivehealthcare.ahrq.govCategories: General Medicine News, PayerTweet
-
Mashup Score: 0Supplemental Evidence and Data Request on Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery - 15 hour(s) ago
The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review on Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery, which is currently being…
Source: www.federalregister.govCategories: General Medicine News, PayerTweet
-
Mashup Score: 2
Individuals from a lower socioeconomic group showed more benefits from low-dose CT screening relating to lung cancer survival.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 3Impact of diagnostic management team on patient time to diagnosis and percent of accurate and clinically actionable diagnoses. | PSNet - 16 hour(s) ago
Diagnostic management teams (DMT), which are comprised of experts in specialized fields, review patient cases and produce reports with diagnostic interpretations and recommendations for future testing or treatments. This pre/post study evaluates the effectiveness of a coagulation DMT at one hospital. Cases reviewed by the DMT were twice as likely to have a diagnostic conclusion (i.e., ruled in or ruled out coagulopathy) than cases without DMT.
Source: psnet.ahrq.govCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality.
Source: www.federalregister.govCategories: General Medicine News, PayerTweet
-
Mashup Score: 5
You are now leaving AstraZeneca-us.com You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit. Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed. Important notice for users You are about to access
Source: www.astrazeneca-us.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality.
Source: www.federalregister.govCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
Grantee Profile
Source: www.ahrq.govCategories: General Medicine News, PayerTweet
#News for #Investors and #Media: At #ASCO24, we shared late-breaking research from a phase III clinical trial evaluating our #MultipleMyeloma therapy. Learn more: https://t.co/dnR2ZMyuV8 https://t.co/ZLy472Jcml